LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Dietary Factors Limit Inflammation and Prevent Colon Cancer

By LabMedica International staff writers
Posted on 28 Aug 2018
Print article
Image: A photomicrograph of a mouse colon from Cyp1a reporter mice after feeding on a diet supplemented with indole-3-carbinol (I3C) (Photo courtesy of Chris Schiering, Francis Crick Institute).
Image: A photomicrograph of a mouse colon from Cyp1a reporter mice after feeding on a diet supplemented with indole-3-carbinol (I3C) (Photo courtesy of Chris Schiering, Francis Crick Institute).
A team of cancer researchers working with a mouse model has found that a chemical generated during digestion of vegetables such kale, cabbage, and broccoli activates a protein that helps maintain the integrity of the cells lining the gut – preventing chronic inflammation that has been implicated in the development of colon cancer.

The epithelium and immune compartment in the intestine are constantly exposed to a fluctuating external environment. Defective communication between these compartments at this barrier surface underlies susceptibility to infections and chronic inflammation.

In this regard, investigators at the Francis Crick Institute (London, United Kingdom) found that generation of intestinal epithelial cells upon injury through infection or chemical insults was profoundly influenced by the environmental sensor aryl hydrocarbon receptor (AHR). This protein is a member of the family of basic helix-loop-helix transcription factors. AHR binds several exogenous ligands such as natural plant flavonoids, polyphenolics, and indoles, as well as synthetic polycyclic aromatic hydrocarbons and dioxin-like compounds.

The investigators reported in the August 14, 2018, online edition of the journal Immunity that mice receiving a diet rich in indole-3-carbinol (I3C), which is produced during digestion of vegetables of the genus Brassica, were protected from gut inflammation and colon cancer. Specific deletion of Ahr from intestinal epithelial cells resulted in failure to control Citrobacter rodentium infection due to unrestricted intestinal stem cell (ISC) proliferation and impaired differentiation, culminating in transformation into cancer cells. AHR activation by dietary ligands, such as I3C, restored barrier homeostasis, protected the stem cell niche, and prevented tumor formation.

"Seeing the profound effect of diet on gut inflammation and colon cancer was very striking," said senior author Dr. Gitta Stockinger, group leader at the Francis Crick Institute. "We often think of colon cancer as a disease promoted by a Western diet rich in fat and poor in vegetable content, and our results suggest a mechanism behind this observation. Many vegetables produce chemicals that keep AhR stimulated in the gut. We found that AhR-promoting chemicals in the diet can correct defects caused by insufficient AhR stimulation. This can restore epithelial cell differentiation, offering resistance to intestinal infections and preventing colon cancer. These findings are a cause for optimism; while we cannot change the genetic factors that increase our risk of cancer, we can probably mitigate these risks by adopting an appropriate diet with plenty of vegetables."

"A number of epidemiological studies suggested that vegetables may be protective against cancer," said Dr. Stockinger. "However, there is very little literature on which vegetables are the most beneficial or why. Now that we have demonstrated the mechanistic basis for this in mice, we are going to investigate these effects in human cells and people. In the meantime, there is certainly no harm in eating more vegetables!"

Related Links:
Francis Crick Institute

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.